Oral treatment may not be far off for head and neck cancer patients 

Features
Published
A highly promising approach to treating HPV-driven head and neck cancer is on the way, and it could be in the shape of a simple oral medication. This is according to new breakthrough research led by Griffith University, which has conducted trials showing that the drug, Alisertib, tested in trials to treat other cancers such as lung and kidney, can also successfully destroy the cancer cells associated with head and neck cancer. Human Papilloma Virus (HPV) […]

Cancer researcher is face of Relay for Life

Features
Published
Griffith University played host to Cancer Council Queensland (CCQ) this week as the charity announced Professor Nigel McMillan as the Face of Relay for Life. Professor McMillan from Griffith Health Institute’s Molecular Basis of Disease program had the honour bestowed on him in recognition of his contribution to cancer research and for his dedication to supporting CCQ’s vision […]